Skip to main content
Veterinary Medicines

CAPSTAR 11.4 MG TABLETS FOR CATS AND SMALL DOGS

Authorised
  • Nitenpyram

Product identification

Medicine name:
CAPSTAR 11.4 MG TABLETS FOR CATS AND SMALL DOGS
Capstar Vet. til katte og små hunde 11,4 mg tabletter
Active substance:
  • Nitenpyram
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Nitenpyram
    11.40
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53BX02
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Cardboard box with 1 polyamide/aluminium/PVC-aluminium blister. Each blister contains 6 tablets.
  • Cardboard box with 10 polyamide/aluminium/PVC-aluminium blisters. Each blister contains 6 tablets.
  • Cardboard box with 1 polyamide/aluminium/PVC-aluminium blister. Each blister contains 1 tablet.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Danish Health And Medicines Authority
Authorisation number:
  • 33597
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0342/001
Concerned member states:
  • Austria
  • Denmark
  • Germany
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish ( TIL KATTE OG SMÅ HUNDE, TABLETTER 11,4 MG)
Published on: 31/10/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."